EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Molecular Imaging of Kidney Diseases

Barbara Mara Klinkhammer, Ilknur Ay, Peter Caravan, Anna Caroli, Peter Boor

Nephron · 01.11.2024 · 1-11

DOI: 10.1159/000542412 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephron, online erschienen am 01.11.2024. Verfasst von Barbara Mara Klinkhammer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Pathology, RWTH Aachen University, Aachen, Germany. Hauptthemen laut MEDLINE: Kidney Diseases, Molecular Imaging. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Diagnosing and monitoring kidney diseases traditionally rely on blood and urine analyses and invasive procedures such as kidney biopsies, the latter offering limited possibilities for longitudinal monitoring and a comprehensive understanding of disease dynamics. Current noninvasive methods lack specificity in capturing intrarenal molecular processes, hindering patient stratification and patient monitoring in clinical practice and clinical trials. Summary: Molecular imaging enables noninvasive and quantitative assessment of physiological and pathological molecular processes. By using specific molecular probes and imaging technologies, e.g., magnetic resonance imaging, positron emission tomography, single-photon emission computed tomography, or ultrasound, molecular imaging allows the detection and longitudinal monitoring of disease activity with spatial and temporal resolution of different kidney diseases and disease-specific pathways. Several approaches have already shown promising results in kidneys and exploratory clinical studies, and validation is needed before implementation in clinical practice. Key Messages: Molecular imaging offers a noninvasive assessment of intrarenal molecular processes, overcoming the limitations of current diagnostic methods. It has the potential to serve as companion diagnostics, not only in clinical trials, aiding in patient stratification and treatment response assessment. By guiding therapeutic interventions, molecular imaging might contribute to the development of targeted therapies for kidney diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney DiseasesMolecular ImagingHumansMagnetic Resonance Imaging

Stichwörter der Autor:innen

Magnetic resonance imagingNoninvasive imagingPositron emission tomographyPrecision nephrologySingle-photon emission computed tomographyUltrasound

Autor:innen und Institutionen

  • Institute for Pathology, RWTH Aachen University, Aachen, Germany.
  • Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Bioengineering Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Klinkhammer, B. M., Ay, I., Caravan, P., Caroli, A., & Boor, P. (2024). Advances in Molecular Imaging of Kidney Diseases. Nephron, 1-11. https://doi.org/10.1159/000542412

Vancouver

Klinkhammer BM, Ay I, Caravan P, Caroli A, Boor P. Advances in Molecular Imaging of Kidney Diseases. Nephron. 2024:1-11. doi:10.1159/000542412

BibTeX
@article{Klinkhammer2024,
  author = {Klinkhammer, Barbara Mara and Ay, Ilknur and Caravan, Peter and Caroli, Anna and Boor, Peter},
  title = {Advances in Molecular Imaging of Kidney Diseases},
  journal = {Nephron},
  year = {2024},
  pages = {1--11},
  doi = {10.1159/000542412}
}
Kostenlos starten →